On Nov 3, 2021 Parthenon Therapeutics closed a Series A round and raised $65,000,000 from Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Northpond Ventures, Park West Asset Management, Pfizer Venture Investments, Section 32, Taiho Ventures, Tekla Capital Management, featuring lead investors Northpond Ventures, Pfizer Venture Investments, Taiho Ventures.

About the company: Parthenon Therapeutics is located at United States, North America.
“Parthenon Therapeutics – Breaking Barriers To Better Cancer Treatment”

Company website: http://www.parthenontx.com